Delivery Order SPE2DB24D2100-SPE2DB25FBGCN
- Not listed
- The Defense Logistics Agency awarded a $2,239.00 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 10 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. The contract was competitively awarded without set-aside designation and is classified as a firm fixed price delivery order, with an ultimate completion date of August 25, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of...
- The Defense Logistics Agency awarded a delivery order valued at $1,328.29 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 10 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. The award, issued on August 15, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 18, 2025. This contract was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,831.88 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 20 mg, a prescription stimulant medication commonly used to treat attention-deficit/hyperactivity disorder. The award, issued on July 8, 2025, with an ultimate completion date of July 9, 2025, represents a firm fixed-price delivery order with no set-aside designation. This order was fulfilled from AmerisourceBergen's place of performance in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,012.76 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 40 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder and narcolepsy. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of July 8, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the...
- The Defense Logistics Agency awarded a delivery order valued at $2,122.77 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 30 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of August 20, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $3,163.85 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 50 mg, a prescription stimulant medication commonly used to treat attention-deficit/hyperactivity disorder. The contract, awarded on July 24, 2025, with completion targeted for July 25, 2025, carries a firm fixed price structure with no set-aside designation, indicating it was competitively awarded. Performance will be fulfilled from AmerisourceBergen's location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,634.42 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 10 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. This competitively awarded, firm fixed-price delivery order was issued on August 26, 2025, with an ultimate completion date of August 27, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a firm fixed-price delivery order valued at $2,048.88 for 100 capsules of Vyvanse 50 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. The contract was competitively awarded without set-aside provisions and carries an ultimate completion date of September 22, 2025. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $6,677.69 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 20 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. The contract was competitively awarded without set-aside provisions and carries a firm fixed price structure with an ultimate completion date of July 31, 2025. AmerisourceBergen will perform this delivery from its corporate headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,052.14 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 60 mg, a prescription stimulant medication commonly used to treat attention-deficit/hyperactivity disorder. The contract is a firm fixed price delivery order with an ultimate completion date of June 20, 2025, and was competitively awarded without set-aside restrictions. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the performing...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBGCNDelivery Order
The Defense Logistics Agency awarded a $5,254.20 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 10 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. The contract, which was competitively awarded without a set-aside designation, carries a firm fixed price structure and an ultimate completion date of September 3, 2025. AmerisourceBergen will perform this work at its corporate headquarters in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 prime vendor agreement valued through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The company's federal contracting history demonstrates consistent competitively awarded contracts with the Defense Logistics Agency across multiple therapeutic categories, positioning it as a critical pharmaceutical distributor for military and veteran healthcare systems. The delivery order reflects routine procurement activity within this established vendor relationship to support ongoing federal medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 9/2/25 |